TagsBioepis

Tag: Bioepis

Healthcare

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan

Ravindra Soni - May 20, 2026 0

Healthcare

Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate

Ravindra Soni - April 15, 2026 0

Healthcare

Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates

Ravindra Soni - March 18, 2026 0

Healthcare

Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide

Ravindra Soni - March 16, 2026 0

Most Read

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

CRIF-SIDBI report: Small business credit portfolio hits ₹50.9 lakh crore in June 2026

October 14, 2026

EDITOR PICKS

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

POPULAR POSTS

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.